SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Feb-24 6:00 PM View: | PharmAthene, Inc. (ALT) | 02-Feb-24 | Payment of Exercise | 8,376 | $9.32 | $78,064.30 | (3%) 300.4K to 292.03K | |
05-Feb-24 6:00 PM View: | PharmAthene, Inc. (ALT) | 02-Feb-24 | Option Exercise | 18,950 | -- | -- | 7% 281.45K to 300.4K | |
05-Feb-24 6:00 PM View: | PharmAthene, Inc. (ALT) | 01-Feb-24 | Payment of Exercise | 7,313 | $9.88 | $72,252.40 | (3%) 288.77K to 281.45K | |
05-Feb-24 6:00 PM View: | PharmAthene, Inc. (ALT) | 01-Feb-24 | Option Exercise | 16,545 | -- | -- | 6% 272.22K to 288.77K | |
01-Feb-24 6:01 PM View: | PharmAthene, Inc. (ALT) | 31-Jan-24 | Grant | 7,889 | $2.69 | $21,221.40 | 3% 264.33K to 272.22K | |
01-Feb-24 6:01 PM View: | PharmAthene, Inc. (ALT) | 30-Jan-24 | Payment of Exercise | 11,697 | $9.80 | $114,631.00 | (4%) 276.03K to 264.33K | |
01-Feb-24 6:01 PM View: | PharmAthene, Inc. (ALT) | 30-Jan-24 | Option Exercise | 26,775 | -- | -- | 11% 249.25K to 276.03K | |
02-Aug-23 5:54 PM View: | PharmAthene, Inc. (ALT) | 31-Jul-23 | Grant | 126 | $2.81 | $354.06 | < 1% 249.13K to 249.25K | |
06-Feb-23 4:30 PM View: | PharmAthene, Inc. (ALT) | 02-Feb-23 | Payment of Exercise | 8,422 | $15.04 | $126,667.00 | (3%) 257.55K to 249.13K | |
06-Feb-23 4:30 PM View: | PharmAthene, Inc. (ALT) | 02-Feb-23 | Option Exercise | 18,950 | -- | -- | 8% 238.6K to 257.55K | |
02-Feb-23 5:09 PM View: | PharmAthene, Inc. (ALT) | 01-Feb-23 | Payment of Exercise | 7,658 | $13.78 | $105,527.00 | (3%) 246.26K to 238.6K | |
02-Feb-23 5:09 PM View: | PharmAthene, Inc. (ALT) | 01-Feb-23 | Option Exercise | 16,546 | -- | -- | 7% 229.71K to 246.26K | |
02-Feb-23 5:09 PM View: | PharmAthene, Inc. (ALT) | 31-Jan-23 | Grant | 1,938 | $10.21 | $19,784.10 | < 1% 227.78K to 229.71K | |
01-Dec-22 4:05 PM View: | PharmAthene, Inc. (ALT) | 30-Nov-22 | Payment of Exercise | 3,007 | $9.95 | $29,919.70 | (1%) 230.78K to 227.78K | |
31-Oct-22 4:05 PM View: | PharmAthene, Inc. (ALT) | 30-Oct-22 | Payment of Exercise | 3,007 | $12.77 | $38,399.40 | (1%) 233.79K to 230.78K | |
03-Oct-22 4:08 PM View: | PharmAthene, Inc. (ALT) | 30-Sep-22 | Payment of Exercise | 3,008 | $12.77 | $38,412.20 | (1%) 236.8K to 233.79K | |
01-Sep-22 4:05 PM View: | PharmAthene, Inc. (ALT) | 31-Aug-22 | Sale (Planned) | 20,000 | $20.02 | $400,322.00 | (8%) 256.8K to 236.8K | |
01-Sep-22 4:05 PM View: | PharmAthene, Inc. (ALT) | 30-Aug-22 | Payment of Exercise | 3,007 | $18.94 | $56,952.60 | (1%) 259.8K to 256.8K | |
12-Aug-22 7:55 PM View: | PharmAthene, Inc. (ALT) | 12-Aug-22 | Private Sale (Planned) | 15,000 | $15.06 | $225,890.00 | (5%) 274.8K to 259.8K | |
01-Aug-22 5:15 PM View: | PharmAthene, Inc. (ALT) | 30-Jul-22 | Payment of Exercise | 3,007 | $12.01 | $36,114.10 | (1%) 277.81K to 274.8K | |
01-Jul-22 4:17 PM View: | PharmAthene, Inc. (ALT) | 30-Jun-22 | Payment of Exercise | 3,007 | $11.70 | $35,181.90 | (1%) 280.82K to 277.81K | |
31-May-22 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-May-22 | Payment of Exercise | 3,008 | $5.03 | $15,130.20 | (1%) 283.83K to 280.82K | |
02-May-22 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-Apr-22 | Payment of Exercise | 3,008 | $4.52 | $13,596.20 | (1%) 286.83K to 283.83K | |
31-Mar-22 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-Mar-22 | Payment of Exercise | 3,007 | $6.05 | $18,192.30 | (1%) 289.84K to 286.83K | |
01-Mar-22 7:01 PM View: | PharmAthene, Inc. (ALT) | 28-Feb-22 | Payment of Exercise | 3,007 | $7.41 | $22,281.90 | (1%) 292.85K to 289.84K | (10%) |
03-Feb-22 7:56 PM View: | PharmAthene, Inc. (ALT) | 01-Feb-22 | Payment of Exercise | 7,655 | $7.98 | $61,086.90 | (3%) 300.5K to 292.85K | |
03-Feb-22 7:56 PM View: | PharmAthene, Inc. (ALT) | 01-Feb-22 | Option Exercise | 16,545 | -- | -- | 6% 283.96K to 300.5K | |
03-Feb-22 7:56 PM View: | PharmAthene, Inc. (ALT) | 31-Jan-22 | Grant | 2,757 | $6.86 | $18,913.00 | < 1% 281.2K to 283.96K | |
31-Jan-22 7:01 PM View: | PharmAthene, Inc. (ALT) | 30-Jan-22 | Payment of Exercise | 2,355 | $7.20 | $16,956.00 | (< 1%) 283.56K to 281.2K | (13%) |
03-Jan-22 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-Dec-21 | Payment of Exercise | 3,007 | $8.93 | $26,852.50 | (1%) 286.56K to 283.56K | 0% |
01-Dec-21 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-Nov-21 | Payment of Exercise | 3,007 | $10.49 | $31,543.40 | (1%) 289.57K to 286.56K | 0% |
01-Nov-21 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-Oct-21 | Payment of Exercise | 3,007 | $10.80 | $32,475.60 | (1%) 292.58K to 289.57K | 0% |
01-Oct-21 7:01 PM View: | PharmAthene, Inc. (ALT) | 30-Sep-21 | Payment of Exercise | 3,007 | $11.31 | $34,009.20 | (1%) 295.58K to 292.58K | 0% |
31-Aug-21 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-Aug-21 | Payment of Exercise | 3,008 | $14.09 | $42,382.70 | (1%) 298.59K to 295.58K | 0% |
02-Aug-21 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-Jul-21 | Payment of Exercise | 3,007 | $9.07 | $27,273.50 | (< 1%) 301.6K to 298.59K | 0% |
01-Jul-21 7:01 PM View: | PharmAthene, Inc. (ALT) | 30-Jun-21 | Payment of Exercise | 3,007 | $9.85 | $29,619.00 | (< 1%) 304.61K to 301.6K | 0% |
02-Jun-21 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-May-21 | Payment of Exercise | 2,577 | $12.65 | $32,599.00 | (< 1%) 307.18K to 304.61K | 1% |
04-May-21 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-Apr-21 | Payment of Exercise | 1,999 | $14.47 | $28,925.50 | (< 1%) 309.18K to 307.18K | 3% |
31-Mar-21 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-Mar-21 | Payment of Exercise | 1,998 | $13.55 | $27,072.90 | (< 1%) 311.18K to 309.18K | 0% |
01-Mar-21 7:00 PM View: | PharmAthene, Inc. (ALT) | 28-Feb-21 | Payment of Exercise | 1,998 | $15.94 | $31,848.10 | (< 1%) 313.18K to 311.18K | (< 1%) |
03-Feb-21 7:00 PM View: | PharmAthene, Inc. (ALT) | 31-Jan-21 | Grant | 1,055 | $12.14 | $12,807.70 | < 1% 312.12K to 313.18K | |
01-Feb-21 7:00 PM View: | PharmAthene, Inc. (ALT) | 30-Jan-21 | Payment of Exercise | 2,353 | $14.28 | $33,600.80 | (< 1%) 314.48K to 312.12K | 0% |
04-Jan-21 5:00 PM View: | PharmAthene, Inc. (ALT) | 30-Dec-20 | Payment of Exercise | 3,025 | $11.30 | $34,182.50 | (< 1%) 317.5K to 314.48K | < 1% |
02-Dec-20 7:05 PM View: | PharmAthene, Inc. (ALT) | 30-Nov-20 | Payment of Exercise | 2,243 | $12.23 | $27,431.90 | (< 1%) 319.74K to 317.5K | (11%) |
02-Nov-20 6:00 PM View: | PharmAthene, Inc. (ALT) | 30-Oct-20 | Payment of Exercise | 2,015 | $11.45 | $23,071.80 | (< 1%) 321.76K to 319.74K | (18%) |
02-Oct-20 6:00 PM View: | PharmAthene, Inc. (ALT) | 30-Sep-20 | Payment of Exercise | 2,015 | $13.20 | $26,598.00 | (< 1%) 323.77K to 321.76K | (3%) |
31-Aug-20 6:01 PM View: | PharmAthene, Inc. (ALT) | 30-Aug-20 | Payment of Exercise | 2,015 | $17.62 | $35,504.30 | (< 1%) 325.79K to 323.77K | 23% |
04-Aug-20 6:40 PM View: | PharmAthene, Inc. (ALT) | 31-Jul-20 | Grant | 11,674 | $1.46 | $17,044.00 | 4% 314.12K to 325.79K | |
03-Aug-20 6:06 PM View: | PharmAthene, Inc. (ALT) | 30-Jul-20 | Payment of Exercise | 2,015 | $26.06 | $52,510.90 | (< 1%) 316.13K to 314.12K | 48% |
01-Jul-20 6:02 PM View: | PharmAthene, Inc. (ALT) | 30-Jun-20 | Payment of Exercise | 2,015 | $10.71 | $21,580.70 | (< 1%) 318.14K to 316.13K | (27%) |